|
|
Previous Article | Table of Contents | Next Article 
Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in
severe combined immunodeficient mice and characterization of the cells
proliferating in vivo
K Imada, A Takaori-Kondo, T Akagi, K Shimotohno, K Sugamura, T Hattori, H Yamabe, M Okuma and T Uchiyama
First Department of Internal Medicine, Kyoto University, Japan.
The mechanism involved in leukemogenesis and neoplastic cell growth of
adult T-cell leukemia (ATL) still remains unclear. We examined the
tumorigenicity of human T-cell leukemia virus type I (HTLV-I)-infected cell
lines in an in vivo cell proliferation model using severe combined
immunodeficient (SCID) mice. Eleven HTLV-I-infected cell lines were
injected into SCID mice and we found that 4 of them were capable of
proliferating in SCID mice. Three of four transplantable cell lines are
derived from the leukemic cell clone and 6 of 6 HTLV-I-infected cell lines
of nonleukemic cell origin could not engraft in SCID mice. Interestingly,
it was shown that some HTLV-I-infected and interleukin-2 (IL-2)-dependent
cell lines could successfully engraft in SCID mice. The expression of IL-2
mRNA was not detected in these cell lines growing either in vivo or in
vitro. HTLV-I viral products were not detected in 3 of 4 transplantable
cell lines proliferating in vivo. Peripheral blood T cells immortalized by
introduction of tax gene of HTLV-I were found to have no tumorigenic
potential in SCID mice. These data suggest that (1) HTLV-I-infected cell
lines of nonleukemic cell origin do not have enough leukemogenic changes to
acquire the tumorigenic potential in SCID mice; (2) the IL-2 autocrine
mechanism is not directly involved in the tumor cell growth; (3) viral gene
expression is not needed for the maintenance of neoplastic cell growth; and
(4) the expression of tax gene is not sufficient for the neoplastic cell
growth in vivo.
Volume 86,
Issue 6,
pp. 2350-2357,
09/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Miyazato, J.-i. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, and M. Matsuoka
De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice
J. Virol.,
November 1, 2006;
80(21):
10683 - 10691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohsugi, R. Horie, T. Kumasaka, A. Ishida, T. Ishida, K. Yamaguchi, T. Watanabe, K. Umezawa, and T. Urano
In vivo antitumor activity of the NF-{kappa}B inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia
Carcinogenesis,
August 1, 2005;
26(8):
1382 - 1388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yagi, T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki, S. Hori, M. Maeda, M. Onodera, T. Uchiyama, S. Fujii, et al.
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Int. Immunol.,
November 1, 2004;
16(11):
1643 - 1656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yoshizuka, R. Moriuchi, T. Mori, K. Yamada, S. Hasegawa, T. Maeda, T. Shimada, Y. Yamada, S. Kamihira, M. Tomonaga, et al.
An Alternative Transcript Derived from the Trio Locus Encodes a Guanosine Nucleotide Exchange Factor with Mouse Cell-transforming Potential
J. Biol. Chem.,
October 15, 2004;
279(42):
43998 - 44004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Dewan, K. Terashima, M. Taruishi, H. Hasegawa, M. Ito, Y. Tanaka, N. Mori, T. Sata, Y. Koyanagi, M. Maeda, et al.
Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/{gamma}cnull Mice: Suppression by an Inhibitor against NF-{kappa}B
J. Virol.,
May 1, 2003;
77(9):
5286 - 5294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Delebecque, K. Pramberger, M.-C. Prevost, M. Brahic, and F. Tangy
A Chimeric Human T-Cell Lymphotropic Virus Type 1 with the Envelope Glycoprotein of Moloney Murine Leukemia Virus Is Infectious for Murine Cells
J. Virol.,
June 27, 2002;
76(15):
7883 - 7889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mori, M. Fujii, K. Iwai, S. Ikeda, Y. Yamasaki, T. Hata, Y. Yamada, Y. Tanaka, M. Tomonaga, and N. Yamamoto
Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells
Blood,
June 15, 2000;
95(12):
3915 - 3921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nosaka, M. Maeda, S. Tamiya, T. Sakai, H. Mitsuya, and M. Matsuoka
Increasing Methylation of the CDKN2A Gene Is Associated with the Progression of Adult T-Cell Leukemia
Cancer Res.,
February 1, 2000;
60(4):
1043 - 1048.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Hisada, A. Okayama, S. Shioiri, D. L. Spiegelman, S. O. Stuver, and N. E. Mueller
Risk Factors for Adult T-Cell Leukemia Among Carriers of Human T-Lymphotropic Virus Type I
Blood,
November 15, 1998;
92(10):
3557 - 3561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hoyle, C. D. Bangs, P. Chang, O. Kamel, B. Mehta, and R. S. Negrin
Expansion of Philadelphia Chromosome-Negative CD3+CD56+ Cytotoxic Cells From Chronic Myeloid Leukemia Patients: In Vitro and In Vivo Efficacy in Severe Combined Immunodeficiency Disease Mice
Blood,
November 1, 1998;
92(9):
3318 - 3327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Takaori-Kondo, K. Imada, I. Yamamoto, A. Kunitomi, Y. Numata, H. Sawada, and T. Uchiyama
Parathyroid Hormone-Related Protein-Induced Hypercalcemia in SCID Mice Engrafted With Adult T-Cell Leukemia Cells
Blood,
June 15, 1998;
91(12):
4747 - 4751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Imura, T. Hori, K. Imada, S. Kawamata, Y. Tanaka, S. Imamura, and T. Uchiyama
OX40 Expressed on Fresh Leukemic Cells From Adult T-Cell Leukemia Patients Mediates Cell Adhesion to Vascular Endothelial Cells: Implication for the Possible Involvement of OX40 in Leukemic Cell Infiltration
Blood,
April 15, 1997;
89(8):
2951 - 2958.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|